Uncategorized-arkiv - QureTech Bio

QureTech Bio appoints three new board members

QureTech Bio appoints three new board members

At the Annual General Meeting of QureTech Bio AB (QTB), [...]

By quretech-cio|2023-05-29T09:06:38+00:00May 29th, 2023|Uncategorized|0 Comments

Professor Scott Hultgren, co-founder of QureTech Bio, elected member of the American Academy of Arts & Sciences

Professor Scott Hultgren, co-founder of QureTech Bio, elected member of the American Academy of Arts & Sciences

Scott Hultgren, co-founder of QureTech Bi, Helen L. Stoever Professor [...]

By quretech-cio|2023-05-29T08:32:54+00:00April 21st, 2023|Uncategorized|0 Comments

QureTech Bio receives excellent support for development of new antibiotics

QureTech Bio receives excellent support for development of new antibiotics

The support is received from the Swedish Research Council's major [...]

By quretech-cio|2023-03-31T11:23:41+00:00March 22nd, 2022|Uncategorized|0 Comments

QureTech Bio Looks to the Future With Appointment of New CEO

QureTech Bio Looks to the Future With Appointment of New CEO

Umeå-based biotech company QureTech Bio has appointed Helén Fält as [...]

By quretech-cio|2021-04-16T14:04:32+00:00January 25th, 2021|Uncategorized|0 Comments

QureTech Bio secures SEK 14 million investment – a very important milestone in their fight against antibiotic resistance

QureTech Bio secures SEK 14 million investment – a very important milestone in their fight against antibiotic resistance

Venture capital company Nascent Invest has bought shares in Umeå-based [...]

By quretech-cio|2020-10-30T11:19:55+00:00October 30th, 2020|Uncategorized|0 Comments

Researchers from Quretech Bio AB awarded additional funding

Researchers from Quretech Bio AB awarded additional funding

Researchers from Quretech Bio AB (Quretech Bio) in Umeå, who [...]

By quretech-cio|2019-12-12T15:17:18+00:00November 14th, 2019|Uncategorized|0 Comments

Quretech Bio – fighting bacterial virulence

Quretech Bio – fighting bacterial virulence

Quretech Bio develops innovative antibiotics by stopping bacterial virulence with [...]

By quretech-cio|2019-12-12T15:21:50+00:00November 13th, 2019|Uncategorized|0 Comments

This website uses cookies and embedded services from third parties. To change the settings and see more detailed information see our Settings Allow all cookies

Third Party Embeds

This website uses cookies and third party services. These features include embedding content such as videos or sharing website content on social media platforms. You can approve by clicking on the content that you allow to be displayed. Then save by clicking Update Settings.

YouTube
Vimeo
Facebook
Google Maps

Tracking Cookies

These cookies store information such as the number of visitors to the website, the number of unique visitors, which pages on the website have been visited, the source of the visit, etc. This data helps us to understand and analyze how well the website works. and where it needs to be improved.

Tracking Cookies

Legal

From 25 May 2018, the General Data Protection Regulation (GDPR) applies as law in all EU member states.

Read our Privacy Policy

Contact Information

Contact us at info@quretech.com if you have questions about how your personal data is processed by us, or if you wish us to change / delete your personal data.